STRATA - Stratification of Asthma Treatment by Breath Analysis

STRATA - 通过呼吸分析对哮喘治疗进行分层

• 批准号: 971449
• 金额: $ 18.95万
• 依托单位: OWLSTONE LIMITED
• 依托单位国家: 英国
• 项目类别: Small Business Research Initiative
• 财政年份: 2016
• 资助国家: 英国
• 起止时间: 2016 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=971449
• 关键词: STRATA; Stratification; Asthma; Treatment; Breath

Too many asthma patients are currently on the wrong medication. As a result there are 54,000 emergency hospital admission and 1,167 deaths every year. In STRATA, Owlstone will adapt our existing disease breathalyzer technology to stratify asthma patients to match them to the correct existing treatments first time. In doing so we will reduce emergency hospital admissions by 30%, save the NHS £81M over 5 years and most importantly save lives.

目前，许多哮喘患者正在服用错误的药物。因此，每年有54 000人急诊入院，1 167人死亡。在STRATA中，Owlstone将调整我们现有的疾病呼吸测醉器技术，对哮喘患者进行分层，以便第一时间将他们与正确的现有治疗方法相匹配。通过这样做，我们将减少30%的急诊入院率，在5年内为NHS节省8100万英镑，最重要的是挽救生命。